Brief: D.Western Therapeutics Institute to sign option license contract for glaucoma treatment drug H-1129
02/02/2017 07:00
Feb 2 (Reuters) - D.Western Therapeutics Institute Inc
4576.T :
* Says co plans to enter into option license contract on
exclusive abroad development and sale right for glaucoma
treatment drug H-1129
Source text in Japanese: https://goo.gl/a3MFBT
Further company coverage: 4576.T
(Beijing Headline News)
((Beijing.HeadlineNews@thomsonreuters.com; +86 62674724;
Reuters Messaging: Cheng.Li@thomsonreuters.com@reuters.net))